Pharmaceutical / Drug Definition :
Suppresses CNS stimulation at limbic and subcortical levels by potentiating effects of gamma-aminobutyrate, an inhibitory neurotransmitter. This suppression reduces anxiety and diminishes alcohol withdrawal symptoms.
In the United States, Oxazepam is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Oxazepam.
Registrar Corp assists Oxazepam companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Oxazepam (Oxazepam Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Oxazepam (Oxazepam Suppliers)
- Processors Oxazepam
- Repackers Oxazepam
- Relabelers Oxazepam
- Exporters Oxazepam
- Importers Oxazepam
For more information about Oxazepam, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.